These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 9579567)

  • 61. Endometrial cancer after tamoxifen treatment: a descriptive study of 25 breast cancer patients who subsequently developed endometrial cancer.
    Peters-Engl C; Medl M; Danmayr E; Mirau M; Alth G; Leodolter S
    Anticancer Res; 1996; 16(5B):3241-6. PubMed ID: 8920798
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Scientific review of tamoxifen. Overview from a medical oncologist.
    Carlson RW
    Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-151-S1-7. PubMed ID: 9045312
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Monitoring of postmenopausal women treated with tamoxifen for breast carcinoma].
    Epifani S; Lattarulo S; Maiorino R; Fabiano G
    G Chir; 2000; 21(6-7):310-2. PubMed ID: 10916956
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Is tamoxifen associated with high-risk endometrial carcinomas? A retrospective case series of 196 women with endometrial cancer.
    Rieck GC; Freites ON; Williams S
    J Obstet Gynaecol; 2005 Jan; 25(1):39-41. PubMed ID: 16147692
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Surveillance for endometrial cancer in postmenopausal breast cancer patients taking tamoxifen.
    Sinawat S; Chiyabutra T; Kleabkaew P
    Asian Pac J Cancer Prev; 2003; 4(4):327-30. PubMed ID: 14728591
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.
    Magriples U; Naftolin F; Schwartz PE; Carcangiu ML
    J Clin Oncol; 1993 Mar; 11(3):485-90. PubMed ID: 8383191
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Absence of correlation between risk factors for endometrial cancer and the presence of tamoxifen-associated endometrial polyps in postmenopausal patients with breast cancer.
    Timmerman D; Deprest J; Verbesselt R; Moerman P; De Brabanter J; Vergote I
    Eur J Cancer; 2000 Sep; 36 Suppl 4():S40-2. PubMed ID: 11056312
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Endometrial adenocarcinoma appearing during tamoxifen therapy. Report of a clinical case].
    Menada MV; Corticelli A; Giannesi A; Nicoletti L; Podesta M; Rissone R; Fulcheri E
    Minerva Ginecol; 2000 Dec; 52(12):521-6. PubMed ID: 11310150
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Endometrial cancer associated with an increase of CA 15 3 and CA 125 in tamoxifen treated patients with breast cancer].
    Mekić-Abazović A; Beculić H; Musić M; Fajkić A; Dervisević S
    Med Glas (Zenica); 2011 Feb; 8(1):68-71. PubMed ID: 21263400
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening.
    Love CD; Muir BB; Scrimgeour JB; Leonard RC; Dillon P; Dixon JM
    J Clin Oncol; 1999 Jul; 17(7):2050-4. PubMed ID: 10561257
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tamoxifen and risk of endometrial cancer.
    Narod SA; Pal T; Graham T; Mitchell M; Fyles A
    Lancet; 2001 Jan; 357(9249):65-6; author reply 67. PubMed ID: 11197376
    [No Abstract]   [Full Text] [Related]  

  • 73. Tamoxifen and risk of endometrial cancer.
    Marsh F; Mayfield M
    Lancet; 2001 Jan; 357(9249):68. PubMed ID: 11197382
    [No Abstract]   [Full Text] [Related]  

  • 74. Tamoxifen and risk of endometrial cancer.
    Dickson MJ; Pandiarajan T
    Lancet; 2001 Jan; 357(9249):67-8. PubMed ID: 11197380
    [No Abstract]   [Full Text] [Related]  

  • 75. Tamoxifen and risk of endometrial cancer.
    Tempfer C; Kubista E
    Lancet; 2001 Jan; 357(9249):65; author reply 67. PubMed ID: 11197377
    [No Abstract]   [Full Text] [Related]  

  • 76. Tamoxifen and risk of endometrial cancer.
    Atkins CD
    Lancet; 2001 Jan; 357(9249):65; author reply 67. PubMed ID: 11197378
    [No Abstract]   [Full Text] [Related]  

  • 77. Tamoxifen and risk of endometrial cancer.
    Lasset C; Bonadona V; Mignotte H; Brémond A
    Lancet; 2001 Jan; 357(9249):66-7. PubMed ID: 11197379
    [No Abstract]   [Full Text] [Related]  

  • 78. Tamoxifen and risk of endometrial cancer.
    Kairies P
    Lancet; 2001 Jan; 357(9249):68. PubMed ID: 11197381
    [No Abstract]   [Full Text] [Related]  

  • 79. Tamoxifen and the risk of endometrial cancer in Japanese women with breast cancer.
    Yamazawa K; Miyazawa Y; Suzuki M; Wakabayashi M; Kaku H; Matsui H; Sekiya S
    Surg Today; 2006; 36(1):41-6. PubMed ID: 16378192
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of tamoxifen on cervicovaginal smears from patients with breast cancer.
    Abadi MA; Barakat RR; Saigo PE
    Acta Cytol; 2000; 44(2):141-6. PubMed ID: 10740597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.